Literature DB >> 16545901

Leukemia inhibitory factor gene mutations in the population of infertile women are not restricted to nulligravid patients.

Milena Kralickova1, Radek Sima, Tomas Vanecek, Petr Sima, Zdenek Rokyta, Zdenka Ulcova-Gallova, Renata Sucha, Petr Uher, Ondrej Hes.   

Abstract

OBJECTIVE: Leukemia inhibitory factor (LIF) is one of the key cytokines in the embryo implantation regulation. We investigated the prevalence of the LIF gene mutations in the population of infertile women that consisted of nulligravid and secondary infertile patients. STUDY
DESIGN: We designed a LIF gene mutation screening method that is based on the Temperature Gradient Gel Electrophoresis (TGGE). The population to screen consisted of 176 infertile women including group A of 147 nulligravid women and group B of 29 women with secondary infertility that had a history of either miscarriage or an ectopic pregnancy but no live births. The control population was comprised of 75 healthy fertile subjects. The groups of fertile controls and infertile patients were compared for statistically significant differences using the t-test.
RESULTS: Six potentially functional LIF gene mutations, the G to A transitions at the position 3400 leading to the valin to methionin exchange at codon 64 (V64M) in the AB loop region of the LIF protein, were detected. All of the six positive women were infertile. Four of them were nulligravid and two of them had history of spontaneous conception followed by early miscarriage. No positive TGGE samples were identified in the control group, which means that the frequency of functionally relevant mutations of the LIF gene in infertile women is significantly enhanced in comparison with controls (P<0.05, t-test).
CONCLUSION: The results suggest that the LIF gene mutations affect fertility. Even though they occur infrequently, their impact on molecular events during early phases of pregnancy should be further established.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16545901     DOI: 10.1016/j.ejogrb.2006.02.008

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

Review 1.  Role of the leukemia-inhibitory factor gene mutations in infertile women: the embryo-endometrial cytokine cross talk during implantation--a delicate homeostatic equilibrium.

Authors:  M Králícková; P Síma; Z Rokyta
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

2.  Assessment of leukemia inhibitory factor and glycoprotein 130 expression in endometrium and uterine flushing: a possible diagnostic tool for impaired fertility.

Authors:  Manal A Tawfeek; Manal A Eid; Azza M Hasan; Manal Mostafa; Hesham A El-Serogy
Journal:  BMC Womens Health       Date:  2012-04-20       Impact factor: 2.809

Review 3.  The Th1/Th2 paradigm: still important in pregnancy?

Authors:  Gérard Chaouat
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 11.759

4.  Pilot study on molecular quantitation and sequencing of endometrial cytokines gene expression and their effect on the outcome of in vitro fertilization (IVF) cycle.

Authors:  D Sabry; O Nouh; S Marzouk; A Hassouna
Journal:  J Adv Res       Date:  2013-08-22       Impact factor: 10.479

5.  V64M Mutation in Leukemia Inhibitory Factor Gene in Women Infertility.

Authors:  Gholamreza Niaei; Bita Amir Taghavi; Amir Niaei
Journal:  Iran J Public Health       Date:  2017-07       Impact factor: 1.429

6.  Association of the leukemia inhibitory factor gene mutation and the antiphospholipid antibodies in the peripheral blood of infertile women.

Authors:  M Králícková; Z Ulcová-Gallová; R Síma; T Vanecek; P Síma; J Krizan; R Suchá; P Uher; O Hes; Z Novotný; Z Rokyta; V Vetvicka
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.